Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists
US10538526B2 · kind B2 · utility
0Cited by
17References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 2018 |
| Grant date | Jan 21, 2020 |
| Priority date | — |
| Expiry date | Sep 15, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.